13 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 13 best biotech penny stocks to buy now.
Vaccinex Inc. (VCNX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 166,000 | $564,400 | +43% | 0% |
| 2. | Armistice Capital Steven Boyd | 164,000 | $557,600 | +75% | 0% |
| 3. | AIGH Investment Partners Orin Hirschman | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.51 | 100 | Large Shareholder, Director | 780,624 | 2024-08-09 | Filing | |
| $4.92 | 2,753 | Large Shareholder, Director | 780,524 | 2024-08-06 | Filing | |
| $4.60 | 3,653 | Large Shareholder, Director | 777,771 | 2024-08-05 | Filing | |
| $4.72 | 11,703 | Large Shareholder, Director | 774,118 | 2024-08-01 | Filing | |
| $7.40 | 16,128 | Large Shareholder, Director | 762,415 | 2024-07-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.72 | 3,149 | Director | 0 | 2023-12-26 | Filing | |
| $0.67 | 1,334 | Director | 3,149 | 2023-12-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 46,719.928,571,429 | $434,832 | 0.23% | |
| 2. | 3,444.3,571,428,571 | $32,057 | 0% | |
| 3. | 1,154.2,142,857,143 | $10,743 | 0% | |
| 4. | 1,150 | $10,703 | 0% | |
| 5. | 838.35,714,285,714 | $7,803 | 0% |
News See All
Is Vaccinex, Inc. (VCNX) Burning These Hedging Funds ?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Fund and Insider Trading News: David Einhorn, Michael Hintze, Neil Woodford, Och-Ziff Capital Management, Universal Forest Products, Inc. (UFPI), Bristol-Myers Squibb Co (BMY), and More
David Einhorn has earned the attention of the investment community.
Hedge Fund and Insider Trading News: Michael Novogratz, David Tepper, Citadel, ValueAct Capital, Ligand Pharmaceuticals Inc. (LGND), Vaccinex Inc (VCNX), and More
Hedge fund manager turned cryptocurrency investor Michael Novogratz cautioned that the stock market is nearing the end of its historic rally.
Billionaire Hedge Funds
